BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33107227)

  • 21. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
    Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.
    Catalona WJ; Southwick PC; Slawin KM; Partin AW; Brawer MK; Flanigan RC; Patel A; Richie JP; Walsh PC; Scardino PT; Lange PH; Gasior GH; Loveland KG; Bray KR
    Urology; 2000 Aug; 56(2):255-60. PubMed ID: 10925089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
    Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium.
    Song ZJ; Qian JK; Yang Y; Wu HX; Wang MY; Jiang SY; Wang FB; Zhang W; Chen R;
    Asian J Androl; 2021; 23(3):300-305. PubMed ID: 33208562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer.
    Yu HJ; Lai MK
    Urology; 1998 May; 51(5A Suppl):125-30. PubMed ID: 9610567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PSA density and prostate cancer detection.
    Saema A; Kochakarn W; Lertsithichai P
    J Med Assoc Thai; 2012 May; 95(5):661-6. PubMed ID: 22994025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low-risk prostate cancer.
    Porcaro AB; Inverardi D; Corsi P; Sebben M; Cacciamani G; Tafuri A; Processali T; Pirozzi M; Mattevi D; De Marchi D; Amigoni N; Rizzetto R; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Minerva Urol Nefrol; 2020 Feb; 72(1):66-71. PubMed ID: 30298710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of prostate volume, PSAD and F/T in the detection of prostate cancer in males with PSA 4-10 μg/L].
    Liu M; Hou HM; Li X; Zhang YQ; Wan B; Wang JY; Jin B
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):526-9. PubMed ID: 27531267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer detection by prostate-specific antigen-related parameters.
    Segawa N; Gohji K; Iwamoto Y; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population.
    Wu YS; Wu XB; Zhang N; Jiang GL; Yu Y; Tong SJ; Jiang HW; Mao SH; Na R; Ding Q
    Asian J Androl; 2018; 20(4):324-329. PubMed ID: 29405172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
    Djavan B; Zlotta AR; Remzi M; Ghawidel K; Bursa B; Hruby S; Wolfram R; Schulman CC; Marberger M
    Urology; 1999 Nov; 54(5):846-52. PubMed ID: 10565745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of prostate health index to identify aggressive prostate cancer. An Institutional validation study.
    Morote J; Celma A; Planas J; Placer J; Ferrer R; de Torres I; Pacciuci R; Olivan M
    Actas Urol Esp; 2016; 40(6):378-85. PubMed ID: 26923032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone.
    Guo ZF; Yang F; Lu XW; Wu JW; He C; Han CH
    J Int Med Res; 2021 Jul; 49(7):3000605211019879. PubMed ID: 34308690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retrospective evaluation of PSA density for selection of biopsy candidates with prostate specific antigen in the gray zone].
    Tochigi T; Kawamura S; Numahata K; Tokuyama S; Kuwahara M; Horaguchi T; Satou S
    Nihon Hinyokika Gakkai Zasshi; 2001 Sep; 92(6):609-14. PubMed ID: 11593702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
    Ohori M; Dunn JK; Scardino PT
    Urology; 1995 Nov; 46(5):666-71. PubMed ID: 7495118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
    Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
    BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is PSA density still useful in diagnosing prostate cancer?
    Pepe P; Candiano G; Fraggetta F; Galia A; Grasso G; Allegro R; Aragona F
    Arch Ital Urol Androl; 2009 Dec; 81(4):199-202. PubMed ID: 20608140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.